Earnings ESP: Molina Healthcare has an Earnings ESP of -5.41%. You can uncover the best stocks before they're reported with our Earnings ESP Filter. Zacks Rank: MOH currently carries a Zacks Rank of 4 (Sell). Factors to Note The growing customer base in the Medicaid and Medicare businesses of Molina Healthcare is expected to have contributed to premium growth, the most significant contributor to the top line of a health insurer, in the second quarter. The Zacks Consensus Estimate for premiums indicates grow ...

Molina Healthcare Q1 Earnings Beat on Growing Membership It has been about a month since the last earnings report for Molina (MOH) . Shares have lost about 3.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Molina due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalyst ...

Molina Healthcare, Inc. (MOH) reported first-quarter 2024 adjusted earnings per share (EPS) of $5.73, which beat the Zacks Consensus Estimate by 5%. However, the bottom line dipped 1.4% year over year.Total revenues amounted to $9.9 billion, which improved 21.9% year over year. Also, the top line outpaced the consensus mark by 4.3%.The quarterly results were aided by membership growth in each of the business lines of Molina Healthcare. This, in turn, drove premiums, the most significant contributor to a hea ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) (State ...

Molina (MOH) reported $9.93 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 21.9%. EPS of $5.73 for the same period compares to $5.81 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $9.52 billion, representing a surprise of +4.32%. The company delivered an EPS surprise of +4.95%, with the consensus EPS estimate being $5.46.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

Revenue Growth - Revenue increased by 15% year-over-year, driven by strong performance in the North American market [1]. - The company achieved a record-breaking revenue of $5 billion in Q4, surpassing market expectations [2]. - Revenue from the EMEA region grew by 10%, contributing significantly to overall growth [3]. Cost Management - Operating expenses were reduced by 8% due to efficient cost-cutting measures implemented in Q3 [1]. - The company successfully lowered its production costs by 12% through supply chain optimization [4]. - General and administrative expenses remained flat, reflecting strict budget controls [2]. Profitability - Net profit margin improved to 18%, up from 15% in the previous quarter [1]. - The company reported a net income of $1.2 billion, a 20% increase compared to the same period last year [3]. - Gross profit margin expanded to 40%, driven by higher sales volumes and better pricing strategies [4]. Market Expansion - The company entered two new markets in Asia, which are expected to contribute to future revenue growth [2]. - A new distribution center was opened in Europe to support increased demand in the region [3]. - Strategic partnerships were formed with local suppliers in South America to enhance market penetration [4]. Product Innovation - Launched three new products in the tech segment, which received positive market feedback [1]. - R&D investment increased by 15%, focusing on next-generation technologies [2]. - The company introduced a new line of eco-friendly products, aligning with sustainability goals [3]. Shareholder Returns - The board approved a 10% increase in dividend payouts, reflecting strong financial performance [1]. - Share buybacks totaled $500 million, aimed at enhancing shareholder value [4]. - Earnings per share (EPS) rose to $2.50, up from $2.10 in the previous quarter [2]. Operational Efficiency - Production efficiency improved by 15% due to the implementation of advanced manufacturing technologies [1]. - The company reduced its inventory turnover days from 45 to 35, enhancing cash flow [3]. - Employee productivity increased by 10%, driven by new training programs and process improvements [4]. Sustainability Initiatives - The company achieved a 20% reduction in carbon emissions, surpassing its sustainability target [1]. - Renewable energy usage increased to 30% of total energy consumption, up from 25% last year [2]. - A new recycling program was introduced, aiming to reduce waste by 15% annually [3]. Customer Satisfaction - Customer satisfaction scores improved to 90%, the highest in the company's history [1]. - The company launched a new customer loyalty program, which has already attracted 100,000 members [2]. - Net Promoter Score (NPS) increased by 5 points, reflecting stronger customer advocacy [4]. Risk Management - The company strengthened its cybersecurity measures, reducing the risk of data breaches by 30% [1]. - A new risk management framework was implemented, improving overall operational resilience [3]. - Insurance coverage was expanded to mitigate potential financial losses from natural disasters [4]. Workforce Development - Employee retention rates improved to 85%, up from 80% last year [1]. - The company invested $10 million in employee training programs, focusing on skill development [2]. - Diversity and inclusion initiatives were expanded, resulting in a 15% increase in workforce diversity [3].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ________ TO ________ Commission File Number 1-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) Delaware 13-4204626 (State or ot ...

Molina Healthcare, Inc. (NYSE:MOH) Q3 2023 Earnings Conference Call October 26, 2023 8:00 AM ET Company Participants Joe Krocheski – Senior Vice President-Investor Relations Joe Zubretsky – President and Chief Executive Officer Mark Keim – Chief Financial Officer Conference Call Participants Josh Raskin – Nephron Research Kevin Fischbeck – Bank of America Nathan Rich – Goldman Sachs Justin Lake – Wolfe Research Calvin Sternick – JPMorgan Stephen Baxter – Wells Fargo Scott Fidel – Stephens A.J. Rice – UBS Ge ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission file number: 001-31719 MOLINA HEALTHCARE, INC. (Exact name of registrant as specified in its charter) In ...

Financial Data and Key Metrics Changes - The company reported adjusted earnings per diluted share of $5.65 for Q2 2023, representing a 24% year-over-year growth on $8 billion of premium revenue [37] - The consolidated Medical Care Ratio (MCR) for Q2 was 87.5%, reflecting strong medical cost management and at the low end of the long-term target range [20][37] - The adjusted pre-tax margin was 5.3% for Q2, with a year-to-date adjusted pre-tax margin of 5.4% [12][15] Business Line Data and Key Metrics Changes - Medicaid, the flagship business, had an MCR of 88.3% for Q2, consistent with expectations and long-term targets, with year-to-date MCR at 88.4% [20][38] - The Medicare segment reported an MCR of 89.2%, slightly above the long-term target range, with increased utilization in outpatient and professional services [13][46] - The Marketplace business achieved an MCR of 73.7% for Q2, reflecting successful pricing strategies and a return to target margins [21][39] Market Data and Key Metrics Changes - The company experienced a decline of 93,000 Medicaid members during Q2, which was within expectations due to the initial impact of redeterminations [41] - The company anticipates a premium impact of approximately $1.6 billion from members disenrolling, with an expected earnings impact of about $1 per share [27] Company Strategy and Development Direction - The company aims to grow premiums at 13% to 15% through current footprint expansion, strategic initiatives, and accretive acquisitions, targeting $46 billion in premium revenue by 2026 [42] - The acquisition of Bright HealthCare's California Medicare business is expected to add approximately $1.8 billion in premium revenue, with no earnings contribution in the first year [18][43] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving long-term financial targets, with a projected annual earnings per share growth rate of 15% to 18% [19] - The company has not observed any emerging trends that would change membership or financial outlooks during the early stages of the Medicaid redetermination process [25] Other Important Information - The company increased its 2023 adjusted earnings guidance by $0.50 to at least $20.75 per share, driven by strong Q2 performance and higher expected investment income [24][40] - The company maintains a low leverage position with a debt-to-cap ratio of 40% and a trailing 12-month EBITDA ratio of 1.6 times [23] Q&A Session Summary Question: Can you discuss the discussions with states regarding rates and the impact from reverifications? - Management indicated that discussions are ongoing with states about potential rate adjustments due to acuity shifts, with most states committed to ensuring rates remain actuarially sound [54][78] Question: What was the actual benefit from the 2022 final risk adjustment true-up? - Management noted that the risk adjustment data validation impacts margins, and the benefit was cut in half due to margin retention [58][59] Question: How are you thinking about reconnects and disenrollments? - Management expects a high rate of reconnects for members disenrolled for procedural reasons, with states allowing 90 to 120 days for members to reestablish eligibility [90][91] Question: What is the timeline for reaching run rate on the Bright Health acquisition? - Management stated that the timeline for achieving target margins on the Bright acquisition is expected to be by the end of the second year post-acquisition [121] Question: How do you view the marketplace growth versus margin strategy for 2024? - Management reiterated that the strategy remains to achieve mid-single-digit margins while allowing for measured growth in the Marketplace segment [102][103]